Conservative outlets are reporting the FDA could complete its mifepristone "safety review" by September — before the midterms. Here's what that could mean for abortion pill access and telehealth abortion.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.